Trial intelligence / Profile preview

Magnesium Sulfate for Adjuvant Analgesia in Pediatric Burn Dressing Changes

NCT07126795Phase 1Not yet recruiting

Sponsor
Hennepin Healthcare Research Institute
Start
Dec 2027
Primary completion
Dec 2030
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised trial in burn injury comparing Magnesium Sulfate Arm with Normal Saline Placebo Arm (2 arms). Primary endpoints: Severe Adverse Events at 1 year, Protocol Deviations at 1 year and 5 more. Planned start Dec 2027; status: not yet recruiting.

02

Drugs

magnesium sulfate
03

Conditions

burn injury

Beyond the preview

Go deeper on NCT07126795.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07126795.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call